Ultromics

To add a bio or update company history, please click update information.

News from Ultromics

Ultromics raises £40m Series C led by L&G, Allegis Capital and Lightrock to expand AI heart failure diagnostics in the US

31 Jul 2025

Ultromics raises £40m Series C led by L&G, Allegis Capital and Lightrock to expand AI heart failure diagnostics in the US

Ultromics develops AI software that analyses echocardiograms to help clinicians detect hard-to-diagnose heart failure conditions earlier, without requiring new hardware or changes to existing clinical workflows.

Ultromics

Health
Oxford, United Kingdom
£40m
ultromics.com
Update Information

More venture news

Mirae
29 Jul 2026
Mirae lands £4m in funding from Oxford Science Enterprises for conversational AI platform that tracks autoimmune disease between clinic visits
EquityHealth
DITTO
28 Jul 2026
DITTO lands a £4.5m seed round led by FoodLabs to develop evidence-based menstrual health supplements
SeedHealth
TidalSense
24 Jul 2026
TidalSense secures £14m in funding from VCs to roll out AI-driven breath test for lung disease
EquityHealth

Ultromics

News from Ultromics

Ultromics raises £40m Series C led by L&G, Allegis Capital and Lightrock to expand AI heart failure diagnostics in the US

More venture news

Mirae lands £4m in funding from Oxford Science Enterprises for conversational AI platform that tracks autoimmune disease between clinic visits

DITTO lands a £4.5m seed round led by FoodLabs to develop evidence-based menstrual health supplements

TidalSense secures £14m in funding from VCs to roll out AI-driven breath test for lung disease